Mounjaro KwikPen 7.5 mg

Mounjaro KwikPen 7.5 mg/dose contains tirzepatide, a prescription medicine administered by subcutaneous injection. The pre-filled KwikPen contains four doses, with the prescribed dosage and treatment schedule determined by a healthcare professional

Tirzepatide is used in the treatment of type 2 diabetes mellitus in adults, alongside diet and physical activity, in accordance with the approved product information. It may also be prescribed for other approved indications where applicable

Product details

• Brand: Mounjaro

• Product: KwikPen

• Active ingredient: Tirzepatide

• Strength: 7.5 mg per dose

• Pack: 1 pre-filled pen containing 4 doses

• Route of administration: Subcutaneous injection

• Prescription status: Prescription-only medicine

Use only as prescribed and consult the official patient leaflet for instructions, warnings, storage conditions, and possible adverse effects

The origin of this product is from the European Community (EC)